Literature DB >> 21996456

Islet allograft tolerance in the absence of invariant natural killer T cells.

Xiufeng Chu1, Elizabeth Kilpatrick, Xiang Xiao, Wentao Liu, Gulcin Demirci, Mark Exley, Xian C Li.   

Abstract

The invariant NKT cells are involved in both immunity and immune tolerance. However, their roles in transplant models remain controversial. We studied the role of NKT cells in the allograft response using two different strains of NKT deficient mice (CD1d-/- and Jα18-/- mice), and found that CD1d-/- and Jα18-/- mice rejected islet allografts with a similar kinetics as wild type B6 mice. Treatment of CD1d-/- and Jα18-/- mice with donor specific transfusion and anti-CD154 induced donor specific tolerance, which was identical to similarly treated wt B6 mice. The islet allograft tolerance requires Foxp3(+) Tregs. In the periphery, Foxp3(+) Tregs in CD1d-/-, Jα18-/-, and wt B6 mice were comparable both phenotypically and functionally. In addition, CD1d-/- and Jα18-/- CD4(+) T cells (non-Tregs) could be readily converted to Foxp3(+) Tregs by TGF-β in vitro. Our data suggest that islet allograft tolerance can be successfully established without invariant NKT cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996456      PMCID: PMC3221878          DOI: 10.1016/j.clim.2011.09.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

1.  The role of natural killer T cells in costimulation blockade-based mixed chimerism.

Authors:  Patrick-Nikolaus Nierlich; Christoph Klaus; Sinda Bigenzahn; Nina Pilat; Zvonimir Koporc; Ines Pree; Ulrike Baranyi; Masaru Taniguchi; Ferdinand Muehlbacher; Thomas Wekerle
Journal:  Transpl Int       Date:  2010-11       Impact factor: 3.782

Review 2.  An update on regulatory T cells in transplant tolerance and rejection.

Authors:  Xian Chang Li; Laurence A Turka
Journal:  Nat Rev Nephrol       Date:  2010-08-03       Impact factor: 28.314

3.  Natural killer T-cells participate in rejection of islet allografts in the liver of mice.

Authors:  Atsushi Toyofuku; Yohichi Yasunami; Kentaroh Nabeyama; Masahiko Nakano; Masayuki Satoh; Nobuhide Matsuoka; Junko Ono; Toshinori Nakayama; Masaru Taniguchi; Masao Tanaka; Seiyo Ikeda
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

Review 4.  Natural killer T cells: a bridge to tolerance or a pathway to rejection?

Authors:  John-Paul Jukes; Kathryn J Wood; Nick D Jones
Journal:  Transplantation       Date:  2007-09-27       Impact factor: 4.939

5.  Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance.

Authors:  C M Watte; T Nakamura; C H Lau; J R Ortaldo; J Stein-Streilein
Journal:  J Leukoc Biol       Date:  2008-01-11       Impact factor: 4.962

6.  IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.

Authors:  X C Li; P Roy-Chaudhury; W W Hancock; R Manfro; M S Zand; Y Li; X X Zheng; P W Nickerson; J Steiger; T R Malek; T B Strom
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

7.  Recognition of bacterial glycosphingolipids by natural killer T cells.

Authors:  Yuki Kinjo; Douglass Wu; Gisen Kim; Guo-Wen Xing; Michael A Poles; David D Ho; Moriya Tsuji; Kazuyoshi Kawahara; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

8.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

9.  OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.

Authors:  Jamal Zaini; Sita Andarini; Minoru Tahara; Yasuo Saijo; Naoto Ishii; Kazuyoshi Kawakami; Masaru Taniguchi; Kazuo Sugamura; Toshihiro Nukiwa; Toshiaki Kikuchi
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 10.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.